TABLE 1.
Baseline Patient Characteristics at Time of SG
| Characteristic | Value (n = 32) |
|---|---|
| Age, years | 55 (50−61) |
| Sex, female | 23 (72) |
| Race/ethnicity | |
| Caucasian | 19 (60) |
| Hispanic or Latino | 10 (31) |
| African American | 2 (6) |
| Other | 1 (3) |
| Excess body weight, kg | 70.3 (58.9−84.2) |
| BMI, kg/m2 | 45.0 (42.1−49.0) |
| 35–39.9 kg/m2 | 4 (12.5) |
| 40–44.9 kg/m2 | 12 (37.5) |
| 45–49.9 kg/m2 | 9 (28) |
| ≥50 kg/m2 | 7 (22) |
| Number of obesity-related comorbidities | |
| 1 | 8 (25) |
| 2–3 | 17 (53) |
| ≥4 | 7 (22) |
| Obesity-related comorbidities | |
| Diabetes mellitus type 2 | 14 (44) |
| Hypertension | 24 (75) |
| Dyslipidemia | 15 (47) |
| Obstructive sleep apnea | 12 (38) |
| Osteoarthritis | 20 (63) |
| Child-Pugh classification | |
| A | 15 (48) |
| B | 17 (52) |
| Primary etiology of liver disease | |
| Hepatitis C virus | 15 (47) |
| Nonalcoholic fatty liver disease | 10 (31) |
| Alcohol | 3 (10) |
| Hepatitis B virus | 2 (6) |
| Other | 2 (6) |
| HCC* | 5 (16) |
| Laboratory MELD score | 12 (10−13) |
| Serum sodium, mEq/L | 137 (135−139) |
| Total bilirubin, mg/dL | 1.3 (1.0−2.4) |
| INR | 1.2 (1.1−1.4) |
| Serum creatinine, mg/dL | 0.9 (0.73−1.18) |
| Prior cirrhosis complications | |
| Ascites | 14 (44) |
| Hepatic encephalopathy | 12 (38) |
| Variceal bleed | 7 (22) |
| History of TIPS | 5 (16) |
| Serum albumin, g/dL | 3.3 (3.1−3.5) |
| Serum platelet count | 95 (79−141) |
NOTE: Data are given as n (%) or median (IQR). Prior cirrhosis complications are not mutually exclusive.
*
All patients with HCC were within Milan criteria at the time of sleeve gastrectomy.